Login Register Cart 0
Generic placeholder image

Current Drug Delivery

Editor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Application of 32 Full Factorial Design and Desirability Function for Optimizing The Manufacturing Process for Directly Compressible Multi-Functional Co-Processed Excipient

Author(s): Jalpa Patel and Dhaval Mori*

Volume 17, Issue 6, 2020

Page: [523 - 539] Pages: 17

DOI: 10.2174/1567201817666200508094743

Price: $65

Abstract

Background: Developing a new excipient and obtaining its market approval is an expensive, time-consuming and complex process. Compared to that, the co-processing of already approved excipients has emerged as a more attractive option for bringing better characteristic excipients to the market. The application of the Design of Experiments (DoE) approach for developing co-processed excipient can make the entire process cost-effective and rapid.

Objective: The aim of the present investigation was to demonstrate the applicability of the DoE approach, especially 32 full factorial design, to develop a multi-functional co-processed excipient for the direct compression of model drug - cefixime trihydrate using spray drying technique.

Methods: The preliminary studies proved the significant effect of atomization pressure (X1) and polymer ratio (microcrystalline cellulose: mannitol - X2) on critical product characteristics, so they were selected as independent variables. The angle of repose, Carr’s index, Hausner’s ratio, tensile strength and Kuno’s constant were selected as response variables.

Result: The statistical analysis proved a significant effect of both independent variables on all response variables with a significant p-value < 0.05. The desirability function available in Design Expert 11® software was used to prepare and select the optimized batch. The prepared co-processed excipient had better compressibility than individual excipients and their physical mixture and was able to accommodate more than 40 percent drug without compromising the flow property and compressibility.

Conclusion: The present investigation successfully proved the applicability of 32 full factorial design as an effective tool for optimizing the spray drying process to prepare a multi-functional co-processed excipient.

Keywords: Co-processing, spray drying, design of experiment, desirability function, Heckel's equation, Kawakita's equation, optimization.

« Previous
Graphical Abstract

[1]
Nachaegari, S.K.; Bansal, A.K. Coprocessed excipients for solid dosage forms. Pharm. Technol., 2004, 28(1), 52-65.
[2]
Gonnissen, Y.; Remon, J.P.; Vervaet, C. Development of directly compressible powders via co-spray drying. Eur. J. Pharm. Biopharm., 2007, 67(1), 220-226.
[http://dx.doi.org/10.1016/j.ejpb.2006.12.021] [PMID: 17317123]
[3]
Saha, S.; Shahiwala, A.F. Multifunctional coprocessed excipients for improved tabletting performance. Expert Opin. Drug Deliv., 2009, 6(2), 197-208.
[http://dx.doi.org/10.1517/17425240802708978] [PMID: 19239391]
[4]
Chaudhari, P.; Phatak, A.; Desai, U. A review: co processed excipients-an alternative to novel chemical entities. Int. J. Pharmaceut. Chemical Sci., 2012, 1(4), 1480-1498.
[5]
Bolhuis, G.K.; Armstrong, N.A. Excipients for direct compaction--an update. Pharm. Dev. Technol., 2006, 11(1), 111-124.
[http://dx.doi.org/10.1080/10837450500464255] [PMID: 16544915]
[6]
McKenzie, P.; Kiang, S.; Tom, J.; Rubin, A.E.; Futran, M. Can pharmaceutical process development become high tech? AIChE J., 2006, 52(12), 3990-3994.
[http://dx.doi.org/10.1002/aic.11022]
[7]
Weissman, S.A.; Anderson, N.G. Design of Experiments (DoE) and process optimization. A review of recent publications. Org. Process Res. Dev., 2015, 19(11), 1605-1633.
[http://dx.doi.org/10.1021/op500169m]
[8]
Salazar, J.; Heinzerling, O.; Müller, R.H.; Möschwitzer, J.P. Process optimization of a novel production method for nanosuspensions using Design of Experiments (DoE). Int. J. Pharm., 2011, 420(2), 395-403.
[http://dx.doi.org/10.1016/j.ijpharm.2011.09.003] [PMID: 21925582]
[9]
Alaei, S.; Ghasemian, E.; Vatanara, A. Spray drying of cefixime nanosuspension to form stabilized and fast dissolving powder. Powder Technol., 2016, 288, 241-248.
[http://dx.doi.org/10.1016/j.powtec.2015.10.051]
[10]
Daraghmeh, N.; Rashid, I.; Al Omari, M.M.; Leharne, S.A.; Chowdhry, B.Z.; Badwan, A. Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol. AAPS PharmSciTech, 2010, 11(4), 1558-1571.
[http://dx.doi.org/10.1208/s12249-010-9523-8] [PMID: 21052880]
[11]
Eraga, S.O.; Arhewoh, M.I.; Uhumwangho, M.U.; Iwuagwu, M.A. Characterisation of a novel, multifunctional, co-processed excipient and its effect on release profile of paracetamol from tablets prepared by direct compression. Asian Pac. J. Trop. Biomed., 2015, 5(9), 768-772.
[http://dx.doi.org/10.1016/j.apjtb.2015.07.008]
[12]
(a)Yamana, T.; Tsuji, A. Comparative stability of cephalosporins in aqueous solution: ki-netics and mechanisms of degradation. J. Pharm. Sci., 1976, 65(11), 1563-1574.
(b)Zając, M.; Jelińska, A.; Dobrowolski, L.; Oszczapowicz, I. Evaluation of stability of cefuroxime axetil in solid state. J. Pharm. Biomed. Anal., 2003, 32(6), 1181-1187.
[http://dx.doi.org/10.1016/S0731-7085(03)00237-1] [PMID: 12907262]
[13]
Bolz, J.; Wagner, G.; Oelrich, E.; Radtke, D. Cefixime composition; Google Patents, 1998.
[14]
Gohel, M.C.; Jogani, P.D.; Bariya, S.E. Development of agglomerated directly compressible diluent consisting of brittle and ductile materials. Pharm. Dev. Technol., 2003, 8(2), 143-151.
[http://dx.doi.org/10.1081/PDT-120018481] [PMID: 12760565]
[15]
Kawakita, K.; Lüdde, K-H. Some considerations on powder compression equations. Powder Technol., 1971, 4(2), 61-68.
[http://dx.doi.org/10.1016/0032-5910(71)80001-3]
[16]
(a)Nordström, J.; Welch, K.; Frenning, G.; Alderborn, G. On the physical interpretation of the Kawakita and Adams parameters derived from confined compression of granular solids. Powder Technol., 2008, 182(3), 424-435.
[http://dx.doi.org/10.1016/j.powtec.2007.07.009]
(b)Yap, S.F.; Adams, M.J.; Seville, J.P.; Zhang, Z. Single and bulk compression of pharmaceutical excipients: evaluation of mechanical properties. Powder Technol., 2008, 185(1), 1-10.
[http://dx.doi.org/10.1016/j.powtec.2007.09.005]
[17]
(a)Heckel, R. Density-pressure relationships in powder compaction. Trans. Metall. Soc. AIME, 1961, 221(4), 671-675.
(b)Ramberger, R.; Burger, A. On the application of the Heckel and Kawakita equations to powder compaction. Powder Technol., 1985, 43(1), 1-9.
[http://dx.doi.org/10.1016/0032-5910(85)80073-5]
[18]
Patel, S.S.; Patel, N.M.; Soniwala, M.M. Statistical development of a multifunctional directly compressible co-processed excipient using the melt agglomeration technique. Asian J Pharm Sci, 2009, 4(6), 340-356.
[19]
Zhang, J.; Wu, C-Y.; Pan, X.; Wu, C. On identification of critical material attributes for compression behaviour of pharmaceutical diluent powders. Materials (Basel), 2017, 10(7), 845.
[http://dx.doi.org/10.3390/ma10070845] [PMID: 28773204]
[20]
Gohel, M.C.; Parikh, R.K.; Aghara, P.Y.; Nagori, S.A.; Delvadia, R.R.; Dabhi, M.R. Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate. Curr. Drug Deliv., 2009, 6(5), 486-494.
[http://dx.doi.org/10.2174/156720109789941696] [PMID: 19863489]
[21]
Choi, D-H.; Kim, N-A.; Chu, K-R.; Jung, Y-J.; Yoon, J-H.; Jeong, S.H. Material properties and compressibility using Heckel and Kawakita equation with commonly used pharmaceutical excipients. J. Pharm. Investig., 2010, 40(4), 237-244.
[http://dx.doi.org/10.4333/KPS.2010.40.4.237]
[22]
Denny, P. Compaction equations: a comparison of the Heckel and Kawakita equations. Powder Technol., 2002, 127(2), 162-172.
[http://dx.doi.org/10.1016/S0032-5910(02)00111-0]
[23]
(a)Mahmoodi, F.; Klevan, I.; Nordström, J.; Alderborn, G.; Frenning, G. A comparison between two powder compaction parameters of plasticity: the effective medium A parameter and the Heckel 1/K parameter. Int. J. Pharm., 2013, 453(2), 295-299.
[http://dx.doi.org/10.1016/j.ijpharm.2013.06.040] [PMID: 23810817]
(b)Wang, S.; Li, J.; Lin, X.; Feng, Y.; Kou, X.; Babu, S.; Panicucci, R. Novel coprocessed excipients composed of lactose, HPMC, and PVPP for tableting and its application. Int. J. Pharm., 2015, 486(1-2), 370-379.
[http://dx.doi.org/10.1016/j.ijpharm.2015.03.069] [PMID: 25841572]
[24]
Desai, P.M.; Liew, C.V.; Heng, P.W.S. Understanding disintegrant action by visualization. J. Pharm. Sci., 2012, 101(6), 2155-2164.
[http://dx.doi.org/10.1002/jps.23119] [PMID: 22422140]

Rights & Permissions Print Cite
Article Metrics
27
2
© 2024 Bentham Science Publishers | Privacy Policy